State Of Wisconsin Investment Board Gilead Sciences, Inc. Transaction History

State Of Wisconsin Investment Board

$36.2 Billion
Q2 2024

A detailed history of State Of Wisconsin Investment Board transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, State Of Wisconsin Investment Board holds 731,976 shares of GILD stock, worth $61.2 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares

731,976

Previous 733,845 0.25%

Holding current value

$61.2 Million

Previous $53.8 Million 6.57%

% of portfolio

0.14%

Previous 0.15%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$63.15 - $72.88 $118,027 - $136,212	-1,869 Reduced 0.25%	731,976 $50.2 Million
Q1 2024 May 14, 2024	BUY	$71.58 - $87.29 $4.46 Million - $5.44 Million	62,362 Added 9.29%	733,845 $53.8 Million
Q4 2023 Feb 12, 2024	BUY	$73.27 - $83.09 $570,480 - $646,938	7,786 Added 1.17%	671,483 $54.4 Million
Q3 2023 Nov 14, 2023	SELL	$73.94 - $80.67 $4.35 Million - $4.75 Million	-58,857 Reduced 8.15%	663,697 $49.7 Million
Q2 2023 Aug 14, 2023	BUY	$76.01 - $86.7 $3.53 Million - $4.03 Million	46,479 Added 6.87%	722,554 $55.7 Million
Q1 2023 May 15, 2023	SELL	$77.31 - $88.08 $286,047 - $325,896	-3,700 Reduced 0.54%	676,075 $56.1 Million
Q4 2022 Feb 14, 2023	SELL	$62.32 - $89.47 $3.02 Million - $4.34 Million	-48,506 Reduced 6.66%	679,775 $58.4 Million
Q3 2022 Nov 14, 2022	SELL	$59.54 - $68.01 $10.8 Million - $12.3 Million	-180,561 Reduced 19.87%	728,281 $44.9 Million
Q2 2022 Aug 15, 2022	SELL	$57.72 - $65.01 $1.96 Million - $2.21 Million	-34,024 Reduced 3.61%	908,842 $56.2 Million
Q1 2022 May 13, 2022	SELL	$57.92 - $72.58 $11.2 Million - $14.1 Million	-194,173 Reduced 17.08%	942,866 $56.1 Million
Q4 2021 Feb 11, 2022	BUY	$64.88 - $73.64 $19.6 Million - $22.2 Million	301,440 Added 36.07%	1,137,039 $82.6 Million
Q3 2021 Nov 12, 2021	SELL	$67.69 - $73.03 $14.3 Million - $15.4 Million	-211,068 Reduced 20.17%	835,599 $58.4 Million
Q2 2021 Aug 12, 2021	BUY	$63.47 - $69.35 $19.4 Million - $21.2 Million	305,662 Added 41.25%	1,046,667 $72.1 Million
Q1 2021 May 17, 2021	SELL	$60.0 - $68.46 $18.3 Million - $20.9 Million	-305,170 Reduced 29.17%	741,005 $47.9 Million
Q4 2020 Feb 03, 2021	SELL	$56.65 - $64.55 $4.44 Million - $5.06 Million	-78,436 Reduced 6.97%	1,046,175 $61 Million
Q3 2020 Nov 16, 2020	SELL	$62.1 - $78.08 $1.85 Million - $2.32 Million	-29,720 Reduced 2.57%	1,124,611 $71.1 Million
Q2 2020 Aug 12, 2020	BUY	$72.34 - $84.0 $24.7 Million - $28.7 Million	341,702 Added 42.05%	1,154,331 $88.8 Million
Q1 2020 May 06, 2020	SELL	$62.63 - $80.22 $49.2 Million - $63 Million	-785,723 Reduced 49.16%	812,629 $60.8 Million
Q4 2019 Feb 14, 2020	SELL	$61.62 - $67.78 $223,680 - $246,041	-3,630 Reduced 0.23%	1,598,352 $104 Million
Q3 2019 Nov 12, 2019	SELL	$62.51 - $69.0 $565,402 - $624,105	-9,045 Reduced 0.56%	1,601,982 $102 Million
Q2 2019 Aug 14, 2019	BUY	$61.87 - $69.38 $1.74 Million - $1.95 Million	28,147 Added 1.78%	1,611,027 $109 Million
Q1 2019 May 13, 2019	SELL	$62.53 - $70.05 $11.6 Million - $13 Million	-184,961 Reduced 10.46%	1,582,880 $103 Million
Q4 2018 Feb 11, 2019	SELL	$60.54 - $79.0 $10.1 Million - $13.2 Million	-166,940 Reduced 8.63%	1,767,841 $111 Million
Q3 2018 Nov 14, 2018	SELL	$71.28 - $78.92 $637,243 - $705,544	-8,940 Reduced 0.46%	1,934,781 $149 Million
Q2 2018 Aug 03, 2018	SELL	$64.88 - $75.68 $4.19 Million - $4.89 Million	-64,610 Reduced 3.22%	1,943,721 $138 Million
Q1 2018 May 07, 2018	BUY	$72.84 - $88.8 $4.11 Million - $5.01 Million	56,413 Added 2.89%	2,008,331 $151 Million
Q4 2017 Feb 08, 2018	BUY	$71.15 - $83.52 $430,742 - $505,630	6,054 Added 0.31%	1,951,918 $140 Million
Q3 2017 Nov 01, 2017	BUY	$72.11 - $85.47 $140 Million - $166 Million	1,945,864	1,945,864 $158 Million

Others Institutions Holding GILD

# of Institutions

1,879

Shares Held

1.02B

Call Options Held

12M

Put Options Held

8.96M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $105B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wisconsin Investment Board with notifications on news.

Account

State Of Wisconsin Investment Board Gilead Sciences, Inc. Transaction History